BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19447578)

  • 1. [Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].
    Nouijai A; Mounach A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Presse Med; 2009 Oct; 38(10):e17-20. PubMed ID: 19447578
    [No Abstract]   [Full Text] [Related]  

  • 2. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.
    Ostor AJ; Crisp AJ; Somerville MF; Scott DG
    BMJ; 2004 Nov; 329(7477):1266. PubMed ID: 15564258
    [No Abstract]   [Full Text] [Related]  

  • 4. [TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].
    Tengstrand B; Ernestam S; Engvall IL; Rydvald Y; Hafström I
    Lakartidningen; 2005 Dec 5-11; 102(49):3788-90, 3793. PubMed ID: 16408702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Puéchal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J
    Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab.
    Mori S; Koga Y; Imamura F; Cho I; Sugimoto M
    Mod Rheumatol; 2007; 17(6):500-6. PubMed ID: 18084704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.
    El Aidli S; Gaïes E; Cherif F; Zaiem A; Daghfous R; Lakhal M
    Presse Med; 2014 Sep; 43(9):1012-4. PubMed ID: 24742611
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.
    Fresko I; Seyahi E; Yurdakul S
    Arthritis Rheum; 2004 Dec; 50(12):4077; author reply 4077-8. PubMed ID: 15593208
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe interstitial pneumonitis associated with infliximab therapy.
    Chatterjee S
    Scand J Rheumatol; 2004; 33(4):276-7. PubMed ID: 15370726
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.
    Schoe A; van der Laan-Baalbergen NE; Huizinga TW; Breedveld FC; van Laar JM
    Arthritis Rheum; 2006 Feb; 55(1):157-9. PubMed ID: 16463430
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal fibrosing alveolitis with certolizumab.
    Millar A; McKew J; Taggart A
    Rheumatology (Oxford); 2012 May; 51(5):953-5. PubMed ID: 22328567
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharyngeal-Cervico-Brachial/Miller Fisher Overlap Syndrome With Infliximab Exposure.
    Yu EH; Geraldi-Samara D
    J Clin Neuromuscul Dis; 2020 Mar; 21(3):157-158. PubMed ID: 32073461
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition.
    Vassallo R; Matteson E; Thomas CF
    Chest; 2002 Sep; 122(3):1093-6. PubMed ID: 12226061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab in primary Sjögren's syndrome: one-year followup.
    Steinfeld SD; Demols P; Appelboom T
    Arthritis Rheum; 2002 Dec; 46(12):3301-3. PubMed ID: 12483735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab therapy in patients with secondary Sjögren's syndrome: functional evaluation.
    Martin Martin LS; Migliore A; Todino V; Pagano A; Chianelli M
    Clin Exp Rheumatol; 2003; 21(3):412. PubMed ID: 12846076
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mixed hepatopathy due to parenteral gold salts].
    González Pérez JA; Calvo Catala J; Herrera Bataller A; Hortelano Martínez E; Folgado Montesinos J; López Maldonado MD
    An Med Interna; 1990 Sep; 7(9):477-9. PubMed ID: 1983295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of fibrosing alveolitis in patients with rheumatoid arthritis treated with chrysanol].
    Repnitskaia ZD; Sunegin KB
    Klin Med (Mosk); 1990 Sep; 68(9):99-100. PubMed ID: 1981247
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy) trial.
    Tsuboi H; Matsumoto I; Hagiwara S; Hirota T; Takahashi H; Ebe H; Yokosawa M; Yagishita M; Takahashi H; Kurata I; Ohyama A; Honda F; Asashima H; Miki H; Umeda N; Kondo Y; Hirata S; Saito K; Tanaka Y; Horai Y; Nakamura H; Kawakami A; Sumida T
    Mod Rheumatol; 2016 Nov; 26(6):891-899. PubMed ID: 27459020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.